Latest Neuroimmunology Stories
The Conrad N.
New position focuses on StemGenex' commitment to safety and efficacy while developing new technology. LA JOLLA, Calif., March 18, 2014 /PRNewswire/ --
Reportbuyer.com just published a new market research report:
GRAND RAPIDS, Mich., July 18, 2011 /PRNewswire/ -- In a study published recently in the journal Science Signaling Van Andel Research Institute (VARI) scientists demonstrate on the molecular level how the anti-malaria drug chloroquine represses inflammation, which may provide a blueprint for new strategies for treating inflammation and a multitude of autoimmune diseases such as arthritis, multiple sclerosis, and certain cancers. "The implications of this study are significant," said Henry F.
Reporting in Nature Immunology, Jefferson neuroscientists have identified a driving force behind autoimmune diseases such as multiple sclerosis (MS), and suggest that blocking this cell-signaling molecule is the first step in developing new treatments to eradicate these diseases.
If you think histamines are your nemesis during allergy season, here's something that might change your perspective.
The complexity of the immune system and nervous system turn Neuroimmunology into one of the most exciting fields of modern biomedicine.
Scientists at Barrow Neurological Institute have recently made discoveries about a type of cell that may limit inflammation in the central nervous system (CNS) â€“ a finding that could have important implications in the treatment of brain disorders such as multiple sclerosis.
- totally perplexed and mixed up.